Oregon Public Employees Retirement Fund’s Tvardi Therapeutics TVRD Stock Holding History

Oregon Public Employees Retirement Fund’s Portfolio TVRD Stock Details TVRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-414	Closed	-$73.2K	–	1711
2023 Q1	$73.2K	Sell	414 -1	-0.2%	-$335	﹤0.01%	1681
2022 Q4	$161K	Sell	415 -1	-0.2%	-$380	﹤0.01%	1623
2022 Q3	$140K	Buy	416 +30	+8%	+$10.9K	﹤0.01%	1622
2022 Q2	$127K	Sell	386 -67	-15%	-$23.5K	﹤0.01%	1491
2022 Q1	$198K	Sell	453 -8	-2%	-$3.28K	﹤0.01%	1626
2021 Q4	$202K	Sell	461 -22	-5%	-$11.1K	﹤0.01%	1519
2021 Q3	$269K	Sell	483 -3	-0.6%	-$1.5K	﹤0.01%	1476
2021 Q2	$250K	Buy	+486	New	+$308K	﹤0.01%	1490

Other funds holding TVRD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Oregon Public Employees Retirement Fund's TVRD Position: Q2 2023 in Review

Oregon Public Employees Retirement Fund sold out of Tvardi Therapeutics (TVRD) in Q2 2023, closing a stake of 414 shares — an estimated $73.2K sold.

Oregon Public Employees Retirement Fund first reported a position in TVRD in Q2 2021 and held it in 8 quarters. The position peaked at $269K in Q3 2021. 137 funds tracked by Wall St. Rank hold TVRD as of Q2 2023.

Oregon Public Employees Retirement Fund reported no remaining Tvardi Therapeutics position as of Q2 2023 after selling out during the quarter.
Oregon Public Employees Retirement Fund sold 414 Tvardi Therapeutics shares in Q2 2023, an estimated $73.2K.
Oregon Public Employees Retirement Fund first reported a position in Tvardi Therapeutics in Q2 2021 and held it in 8 quarters.
Oregon Public Employees Retirement Fund's Tvardi Therapeutics position peaked at $269K in Q3 2021.
137 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q2 2023.

Based on Oregon Public Employees Retirement Fund's 13F filing for Q2 2023, filed 26 Jul 2023.